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INTRODUCTION
Liquor  amnii,  a  fluid  elaborated  by  amnion  a  two  layered  extra 
embryonic  membrane  formed  by  inner  ectoderm  and  outer  somatic 
mesoderm provides fluid medium for the early development of the embryo 
protecting it  from concussion,  pressure,  dessiccation,  reminiscent  of  the 
aquatic origin of life.
Adequate  amount  of  amniotic  fluid  is  essential  for  the  normal 
growth  of  the  fetus  for,it  cushions  against  all  sorts  of  trauma  and 
agitations. Its bacteriostatic properties prevents  infection and it functions 
as a primary source of fetal Nutrients.
In  Normal  Pregancies,  the  volume  of  amniotic  fluid  increases  to 
about one litre at 36 weeks maximum level. Amniotic fluid volume rises 
progressively  during  gestation  until  36  weeks,the  mean  amniotic  fluid 
volume  relatively  consistent  in  the  level  of  700-800ml.After  40weeks 
there is a progressive decline of amniotic fluid volume at a rate of 8 %per 
week, with amniotic fluid volume averaging about 400ml at 42 wks. The 
clinical picture of reduced amniotic volume is termed oligohydramnios.
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Using  amniotic  fluid  index  of  less  than  5cm  the  incidence  of 
oligohydramnios was found to be 2.3% after 34 weeks. Oligohydramnios 
was  associated  with  increased  risk  of  adverse  perinatal  outcome.  The 
umbilical  cord  compression  during  labour  is  common  with 
oligohydramnios which increases the  risk for caesarean delivery for fetal 
distress and 5 minute apgar score less than 7 (Chauhan,1999)
The decrease of amniotic fluid volume is associated with the 
increased labour induction, still birth, non reassuring fetal heart pattern, 
meconium aspiration syndrome and neonatal death.
(Casey & Coworkers ,2000)
This present study is undertaken to asses the perinatal outcome in 
Amniotic fluid index of 5 cm or less (oligohydramnios) in term 
pregnancies.
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AIM OF THE STUDY
To determine the perinatal outcome in term pregnancies with 
Amniotic fluid index <5 cm.
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REVIEW OF LITERATURE
AMNIOTIC FLUID:-
Amniotic  fluid  forms  an  aquatic  pond  inside  the  amniotic 
cavity surrounding the fetus. This fluid provides several important benefits 
to the fetus. Amniotic fluid has a number of important roles in embryo / 
fetal development like.
1. Permitting fetal movement and the development of the 
musculoskeletal system.
2. Swallowing of amniotic fluid enhances the growth and 
development of gastrointestinal tract.
3. Amniotic fluid volume maintains amniotic fluid pressure there by 
reducing the loss of Lung liquid -an essential component to 
pulmonary development (Nicolini,1989)
4. The ingestion of amniotic fluid provides some fetal nutrition and 
essential nutrients.
• Protects the fetus from external trauma
• Protects the umbilical cord from compression
• Its constant temperature helps to maintain the embryo’s body 
temperature
• Its bacteriostatic properties reduce the potential for infection.
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FORMATION OF THE AMNIOTIC FIUID 
The amniotic fluid in the first  trimester is derived from embryo’s 
plasma volume. Because embryonic skin is only 4-cell layers thick , there 
is rapid diffusion across this permeable barrier into the amniotic cavity.
During the embryo-fetal development, three overlapping excretory 
systems develop- pronephros, mesonephros and meta nephros. The 
pronephros and mesonephros are nonfunctional in humans. The metanephri 
begin to develop by 7 weeks menstrual age and are functional by menstrual 
age 10-11 weeks. Because glomerular filtration precedes tubular function 
fetal urine is initially relatively hypotonic As the fetus matures , 
reabsorption of sodium, chloride and water occurs and the excretion of 
urea and  creatinine increases (Mannie IW, 1980)
These alterations in fetal renal function, in part, explain the changes 
that are seen in the composition of amniotic fluid with advancing 
gestational age.
During  the  second  half  of  pregnancy,  the  stratification  and 
cornification of the fetal skin reduces the diffusion of fetal extra cellular 
fluid into the amniotic cavity. But the fetal skin continues to play a role in 
amniotic fluid regulation throughout the pregnancy the importance of this 
pathway is evident in the significantly higher transcutaneous fluid losses of 
preterm infants.
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According to the current concepts of amniotic fluid dynamics 
(Seeds, 1980) there are six routes for fluid entry into and exit from the 
amniotic sac for the late gestation fetus.
These are :
1. Fetal urine : is the major source of Amniotic   fluid after fetal kidney
                         Function which begins at 10-12 weeks of gestation.
2. Fetal swallowing  and reabsorption by intestine 
3. Intra membranous pathway 
4. Secretion from respiratory tract 
5. Oral –Nasal secretions 
6. Transmembranous pathway
Fetal urine is the major contributor to the volume of amniotic fluid in 
the  latter  half  of  pregnancy  of  amniotic  fluid  ion  the  latter  half  of 
pregnancy. It has been estimated that the volume of urine produced per day 
by human foetus  during the latter  half  of  gestation  is  35% of  its  body 
weight (Hedrina,1994)
 
The fetal swallowing of amniotic fluid is evidenced by the presence 
of epidermal debris including lanugo hairs in the meconium It has been 
estimated that the foetus swallows amniotic fluid which is equivalent to 
15% of its Body weight (Pritchard 1965)
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The  pathway  for  exchange  between  amniotic  fluid  and  the  fetal 
blood within the fetal surface of placenta is referred to as intramembranous 
pathway In the pathway water and solutes can move in opposite directions; 
i.e.  osmotic  flow of  water  and  diffusion  of  solutes  occur.  It  has  been 
estimated that 400ml of water is absorbed daily intramembranously from 
the amniotic fluid during late gestation .
Fetal lungs secrete large volumes of fluid each day and less than 1% 
of  this  secreted  fluid  is  needed  to  expand  the  lungs  with  growth  the 
remainder flows out of the lungs and may either enter the amniotic fluid or 
be swallowed as it exits the trachea. The amniotic fluid from the trachea is 
the source of surfactants, which are commonly used as an indicator of fetal 
lung maturity. Only under condition of fetal asphyxia or severe distress do 
the  fetal  lungs  absorb  fluid.  A supporting  observation  is  that,  although 
meconium staining of amniotic fluid is common, aspiration of meconium 
into the lungs of the newborn is relatively uncommon.Lung secretion rates 
are approximately are 10% of fetal body weight daily (Harding R 1994)
Fetal oral and nasal secretions also enter the amniotic fluid, but it 
has been found to be less than 1% of the body weight per day 
(Brace1 R.A.,994)
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In  transmembranous  pathway,  exchange  occurs  between  the 
amniotic fluid and the maternal blood within the uterine wall .This passive 
exchange  is  not  likely  to  be  significant  during  the  latter  half  of  the 
gestation. In recent studies the transmembranous fluid of water was found 
to be as little as 10 ml daily near term under normal conditions 
(Brace 1995)
Pathway(Brace,1997) Volume ml/day 
to the fetus
To Amniotic 
fluid
 
Fetal swallowing 500-1000
 
Oral secretions
25
Secretions from respiratory tract 170 170
Fetal urination 800-1200
In Intramembranous flow across 
the placenta, umbilical cord and 
foetus
Transmembranous flow      
400
-
200-500
10
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REGULATION OF AMNIOTIC FLULD VOLUME
Late  in  gestation  when  the  amniotic  fluid  volume  averages 
700-800ml, 1000 ml daily of fluid flows into the amniotic compartment 
and  1000ml  daily  leaves  the  amniotic  compartment.  Only  minor  or 
moderate  aberrations  in  flows  during  a  period  of  days  to  weeks  could 
readily lead to oligohydramnios or polyhydramnios
There are no known sensors for AFV, could be part of a control loop 
to return AFV toward normal whenever it becomes too high or too low. 
But fetal urine flow, lung liquid secretion and swallowing are known to be 
regulated.  Intramembranous  absorption  is  controlled  by  factors  that 
regulate the intramembranous  permeability and surface area .All of the 
primary flows into and out of amniotic compartment are regulated and it is 
the interaction among these flows that provide the regulation of AFV.
Recent studies (Brace P.A 1997) suggest that even slight changes in 
intramembranous  permeability  can  have  very  large  effects  on 
intramembranous  flux  rates.  Any  substance  e.g.  like  prostaglandins 
excreted by fetal kidneys, or released by amnion or chorion, which enter 
the  amniotic  fluid  could  potentially  alter  intramembranous  permeability 
and thus lead to alterations in AFV.
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Hormonal  factors  also  play  a  role  in  amniotic  fluid  regulation. 
Intraamniotic injection of prolactin has been shown to reduce the amniotic 
fluid  by  50%  by  stimulating  the  transport  of  water  from  the  fetal  to 
maternal  compartment  (Endocrinology  1997). Cortisol  and  antidiuretic 
hormone  also affect the permeability of amnion.
CHANGES IN AFV ACROSS GESTATION 
AFV changes in pregnancy were studied by Brace and wolf 
(1989) and their observations were:
 Amniotic fluid volume rises progressively during gestation until 
approximately 32 weeks .
 From 32 weeks to term, the mean AFV is relatively 
     constant in the range of 700-800ml
 After 40 weeks, there is a progressive decline in amniotic fluid 
volume at a late of 8% per week, with amniotic fluid volume 
averaging only 400ml at 42wrs
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 The variation in ‘normal fluid’ volume below the mean value is 
smaller than the upper variation in the third trimester 
oligohydraminos(defined as the 5th percentile) which is 
approximately 300ml . Variations in the upper range is almost three 
fold greater, so that hydraminos (>95th percentile) varies from 
1700-1900ml.
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OLIGOHYDRAMNIOS
Definition:-
Oligohydramnios is a condition in which the amount of amniotic 
fluid is decreased below the normal level (Normal level- AFI- 8-15 cm)
Various authors have given definition for oligohydramnios.
Technique Definition Redellence
1. Dye dilution 200ml Horsager et al(1994) 
2. Dye dilution 500ml Magann et al (1992)
3. 12studies-Direct 
measurement or dye 
dilution
318ml Brace and wolf (1989) 
4. Ultrasound Single vertical pocket 
<0.5cm
Mercer et al (1984)
5. Ultrasound Single vertical .pocket 
<1cm 
Manning et al (1981)
6. Ultrasound Single Vertical pocket 
<2cm
Manning et al (1990)
7. Ultrasound Single Vertical pocket 
<3cm
Halperin et al and 
crawley et al (1984,1985)
8. Ultrasound Two diameter pocket 
(vertical x 
horizontal)<15cm
Magann et al (1992)
9. Ultrasound AFI<5th percentile for 
GA
Moore (1990)
10.Ultrasound AFI <5 cm Phelan  (1987)
11.Ultrasound AFI <7cm Dizon-Townson(1996)
12.Ultrasound AFI <8cm Jeng et al (1992)
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SONOGRAPIHC ASSESMENT
The  sonographic  assessment  of  amniotic  fluid  volume  is  semi-
quantitative. Historically, the amniotic fluid was simply evaluated visually 
and graded as  decreased,  normal  or  increased.  The  appearance  of  fetal 
crowding  and  an  obvious  lack  of  amniotic  fluid  were  used  to  define 
oligohydramnios.  Goldstein and Filly (1988)  have reported good intra-
observer and inter-observer agreement between subjective assessment and 
single  largest  pocket  determination  of  amniotic  fluid  volume.  One 
disadvantage of the subjective assessment of amniotic fluid volume is an 
inability  to  compare  results  from  serial  examinations  as  the  fetal  or 
maternal condition changes.
Manning and platt (1980) measured the single deepest pocket of 
amniotic fluid free of fetal extremities and umbilical cord to asses amniotic 
fluids  volume  .This  definition  was  found  to  be  restrictive.  Manning 
redefined  normal  amniotic  fluid  as  one  packet  of  amniotic  fluid  that 
measures atleast 2cm in two perpendicular planes. (Manning 1995)
The amniotic fluid index was proposed on a way to more fully 
assess the amount of amniotic fluid throughout the uterine  cavity (phelan 
1987). This method summed the maximum vertical pocket of amniotic 
fluid in each quadrant of the uterus. Oligohydramnios was defined as 
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amniotic fluid index<5cm. Moore and Cayle (1990) obtained AFI’s in 
791 normal pregnancies They defined oligohydramnios as an AFI below 
the 5th percentile for gestational age . This value varies between 7.9cm at 
16 weeks and 6.3cm at 40 weeks gestation. 
Jeng and coworkers (1992) have defined oligohydramnios as an 
AFI <8cm.
AETIOLOGY OF OLIGOHYDRAMNIOS :
A number of conditions have been found to cause diminished 
amniotic fluid .They include (Peipert and Donnenfeld 1991) 
(Sherer,1990)
FOETAL 
- chromosomal abnormalities 
- congenital anomalies 
- Growth restriction 
- Fetal demise 
- Post term pregnancy 
- Ruptured membranes
PLACENTAL
- Abruption
- Twin to twin transfusion
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MATERNAL
-   Uteroplacental insufficiency
-   Hypertension
-   Preeclampsia
-  Diabetes
- Hypovolemia
IATROGENIC
- Drugs like prostaglandin Synthetase inhibitors, 
angiotensin converting enzyme inhibitors, etc.
- chorionic villus sampling.
IDIOPATHIC 
FETAL ANOMALIES AND OLIGOHYDRAMNIOS 
Oligohydramnios occurs when there is either obstruction to fetal 
urinary tract or renal agenesis this occurs due to the anuria.
      16
A number of congenital anomalies have been associated with
oligohydramnios.
They are (Mc curdy and seeds, 1993) (Peipert and 
Donnenfeid 1991)
• Amniotic band syndrome
• Cardiac : Tetralogy of Fallot , septal defects
• Central Nervous System : Holoprosencephaly , meningocele, 
encephalocoele, microcephaly.
• Chromosomal abnormalities : Triploidy, trisomy 18, Turner 
syndrome.
• Cloacal dysgenesis 
• Cystic hygroma 
• Diaphragmatic hernia 
• Genitourinary :Renal agenesis, renal dysplasia,
                     Urethral obstruction, bladder exstrophy,
 Meckel-Gruber syndrome, uretero-pelvic junction, prune-   
 belly syndrome.
•  Hypothyroidism
• Skeletal  - Sirenomelia, Sacral agenesis, absents radius, facial 
      clefting.
• TRAP (twin reverse arterial   perfusion)sequence 
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• Twin to twin transfusion
• VACTERL (vertebral, anal, Cardiac, tracheo- oesophageal,   
      renal, limb) association
The prevalence of congenital anomalies and aneuploidy varies 
between 4.5- 37% and 0.4- 4 % respectively (Nicolaides 1991, 
Shipp,1996)
      The reduction in amniotic fluid volume makes an assessment of fetal 
anatomy  more  difficult.  Transvaginal  sonography  and  colour  or  power 
Doppler (De Vore 1995) can be used to confirm the presence or absence of 
kidneys  and  renal  arteries,  respectively.  Early  symmetric  intrauterine 
growth restriction  and  and oligohydramnios  should  suggest  a  possible 
karyotypic  abnormality (Nicodaides, 1986)
 
INTRAUTERINE GROWTH RESTRICTION AND 
OLIGOHYDRAMNIOS :-
                   
 Historically,  the  association  between  IUGR and  oligohydramnios 
has been attributed to decreased fetal  urine production due to deceased 
uteroplacental  perfusion.  But,recent  animal  studies  have  not  found  that 
hypoxemia affects urine formation. It has been proposed that a reversal of 
   18
intramembranous flow is responsible for oligohydramnios. There is direct 
relationship between decreased amniotic fluid volume and the prevalence 
of IUGR. When a single pocket of amniotic fluid is > 2cm, between 1& 
2cm,  and  <1cm,  the  prevalence  of  IUGR  is  5%  ,  20%  and  37% 
respectively (Chamberlain 1984) 
 POSTTERM PREGNANCIES AND IUGR:-
                          
                There is an acknowledged relationship between prolonged 
pregnancies ( > 42 wks) and an increase perinatal morbidity and mortality 
(Chamberlain  1984;  Eden  1987 )  over  40yrs  ago,  a  relationship  was 
noted between the diminishing  placental function of post maturity  and 
oligohydramnios  (Elliot 1961).  As a result, the ultrasonic assessment of 
amniotic fluid has been used extensively in the antepartum  testing of post 
date pregnancies.
PRETERM RUPTURE OF MEMBRANES AND 
OLIGOHYDRAMINOS
       
              Preterm rupture of membranes is defined as rupture of membranes 
prior  to  37  weeks  gestation.  Spontaneous  rupture  of  the  membranes 
between 24 & 34wks gestation occur in 1.7% pregnancies but account for 
20% of perinatal death. Second trimester oligohydramnios has particularly 
poor prognosis with approximate survival rate 10% (Shipp 1996)
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 IATROGENIC OLIGOHYDRAMNIOS 
          
             Drugs like nonsteroidal prostaglandin synthetase inhibitors inhibit 
renal vascular flow & there by reduce amniotic fluid volume. They also 
cause closure of ductus ateriosus. Prostaglandin synthetase  inhibitors are 
used  in  treatment  of  preterm  labour  and  symptomatic  polyhdramnios 
(Morales 1989,Kiss how 1990).When prostaglandin synthetase inhibitor is 
discontinued,  amniotic  fluid  gradually  reaccumulates.  Serial  ultrasound 
examinations are warranted when late second or third trimester women are 
placed on prostaglandin synthetase inhibitor.   
Exposure to angiotensin converting enzyme inhibitors has been with 
late onset growth restriction and oligohydramnios followed by prolonged 
and  profound  neonatal  hypotension  and  anuria.  The  most  severe 
consequence  in  renal  tubular  agenesis,Which  causes  early  onset 
oligohydramnios, pulmonary hypoplasia & limb contracures and perinatal 
death ( Barr and Cohen 1991) (Pryde and co-workers 1993) (Schubiger 
& associates, 1988)  
             Oligohydramnios is an acknowledged complication of first 
trimester chorionic villus sampling and second trimester genetic 
aminocentesis. If amniotic fluid volume subsequently returns to normal, 
the neonatal outcome is generally good (Shipp 1996, Bronshtein 1991) 
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FETAL HYPOXIA AND OLIGOHYDRAMINOS
In case of maternal diseases like Chronic hypertension, Connective 
tissue  disorders,  severe  preeclampsia,  and  chronic  renal  disease  fatal 
hypoxia  occurs  due  to  uteroplacental  insufficiency.  The  basis  for  this 
association has been derived from animal model (Deutinger, 1987)
Experimental  hypoxia  results  in  a  reflex  redistribution  of  fetal 
cardiac output, that is renal and plumonary flow decrease, hence urinary 
output and production of fluid by the lung decreases and the amount of 
amniotic fluid declines.In pregnant women living at 6000 feet, AFI was 
higher across gestation than in pregnant women at sea level(Yancey 1994)
Hypoxia induced suppression of fetal swallowing is thought to be 
involved in mediating an increase in AFV during long term hypoxia. It is 
speculated that oligohydramnios associated with fetal hypoxia is caused by 
placental dysfunction in addition to the hypoxia.
MATERNAL HYPOVOLEMIA AND OLIGOHYDRAMNIOS:
Acute  maternal  hypovolemia  has  been  found  to  be  cause  of 
oligohyramnios  (Sherer,1990).Studies  show  that  maternal  dehydration 
,particularly  during  a  period  of  days  is  associated  with  a  reduction  in 
amniotic  fluid  volume  .The  changes  in  amniotic  fluid  volume  may  be 
mediated by the changes in intramembranous flow because the water 
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induced  reduction  in  fetal  osmolality  would  be  expected  to  reduce 
intramembranous absorption.(Flack ,1995)
FETAL EFFECTS OF OLIGOHYDRAMNIOS:
Early onset Oligohydramnios has been associated with many fetal 
congenital anomalies and poor fetal outcome (Shenker and 
Colleagues,1991) (Gaemel and co-workers 1997) observed that 
appropriately grown fetus associated with oligohydramnios prior to 37 
weeks had a significant three fold increase in preterm birth.
Adhesions  between  amnion  and  fetal  parts  may  cause  serious 
deformities  including amputation  or  abnormal  positioning of  hands and 
feet.  Subjected  to  pressure  from all  sides,  the  fetus  assumes  a  peculiar 
appearance-Potter facies (i.e. prominent epicanthal folds a flattened nose 
and low set ears) and musculoskeletal deformities.
The incidence of pulmonary hypoplasia is found to be higher with 
oligohydramnios (mossinger collegues & winn and associates, 2000).
According to Fox and Badalian (1994) and Laura and colleagues (1995), 
there  are  three possibilities  that  account  for  pulmonary  hypoplasia.First 
,the  thoracic  compression  may  prevent  chest  wall  excursion  and  lung 
expansion.  Second,  lack  of  breathing  movements  decreases  lung 
inflow.The third and the most widely accepted model involves a failure to 
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retain amniotic fluid or increased outflow with impaired lung growth and 
development.
           Third trimester oligohydramnios may be responsible for 
malpresentaion problems, umblical cord compression, concentration of 
meconium in the liquor and difficult or failed external cephalic Version 
(Hofmeyr, 1991).
Sarno and Co-workers (1989, 1990) reported that AFI of 5 cm or 
less was associated with five fold increased caesarean delivery rate.
Baron and colleagues (1995) reported a 50 % increase in variable 
decelerations during labour and a seven fold increased caesarean delivery.
           Casey and co-workers showed a 25% increase in non-reassuring 
fetal heart rate pattern when women with oligohydramnios were compared 
with normal controls however, the caesarean rate for this increased only 
from 3to5 percent
MANAGEMENT OF OLIGOHYDRAMNIOS
The obstetric management of oligohydramnios is determined by its 
etiology. A careful assessment of both the mother and fetus is necessary 
with primary disease process like placement of a bladder- amniotic shunt 
for  posterior  urethral  valves,  discontinuing  a  prostaglandin  synthetase 
inhibitor etc.,the amniotic fluid will return to normal.
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Intrauterine  growth  restriction  is  managed  with  appropriate 
antepartum testing and determining the optimal time for delivery.
Antibiotics and corticosteroids may be utilized with preterm 
premature rupture of membranes at a gestational age < 32 weeks 
(Vermillion, 2000)
Isolated third trimester oligohydramnios is not necessarily 
associated with poor perinatal outcome (Meganan, 1999)
TRANSABDOMINAL AMNIOINFUSION:
Transabdominal amnioinfusion has been attempted for diagnostic 
and therapeutic purpose in women with second trimester oligohydramnios 
(Quetel, 1992)
By  instilling  40  to  600ml  of  Normal  saline  transabdominally, 
improved visualization in ultrasound was made.  Also, by mixing indigo 
carmine  and  detection  of  the  dye  vaginally  a  diagnosis  of  preterm 
premature rupture of membranes was also made  (Fisk 1991).  Miyazaki 
and  Nevaserz  1985 noted  that  various  decelerations  due  to  cord 
compression are reduced by transabdominal amniofusion.
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TRANSVAGINAL AMINOINFUSION:
      Three predominant indication for this are meconium stained amniotic 
fluid, variable decelerations and prophylactically for oligohydramnios. The 
role  of  amnioinfusion  in  variable  decelerations  or  prophylactically  for 
oligohydramnios  is not clear but multiple randomized studies show that 
amnioinfusion  is  associated  with  significant  decrease  in  meconium 
aspiration and meconium aspiration syndrome(Dye,1994)
MATERNAL HYDRATION:
Intravenous hydration with 6500ml of an isotonic increased amniotic 
fluid volume in markedly dehydrated women (Sherer, 1990)
Brace (1989) showed that changes in maternal intravascular volume 
can alter fetal urine output amniotic fluid volume and to a lesser extent 
intravascular volume.
Kilpatric & co-workers (1991) oral maternal hydration with 2 liters 
of water was associated with an increase in AFI by approximately 30%in 
women with decrease AFI & Normal AFI
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MATERIALS AND METHODS
A prospective study on the perinatal outcome in term pregnancies 
with Amniotic fluid index < 5 cm & control group amniotic fluid index 
>5cms was carried out in Institute of Obstetrics & Gynaecology, 
Government Hospital for Women & Children, attached to Madras 
Medical College, Chennai – 8, during the period of February 2004 to 
January 2006.
INCLUSION CRITERIA:
Pregnant women with gestational age more than 37 weeks and 
Amniotic fluid index 5 cm or less.
EXCLUSION CRITERIA:-
1. Patients with amniotic membrane rupture or draining P/V.
2. Patients with fetus having congenital anomalies like renal 
agencies, polycystic kidneys.
3. Patients with multiple gestation.
4. Patients less than 37 weeks.
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SAMPLE SIZE: 
About 150 cases in AFI < 5cms (Study Group)
And 150 Cases in Control Group (AFI > 5cms)
                
History regarding age, parity, duration of gestation menstrual 
history, obstetric history and history of  any complications in present 
pregnancy were noted.
General  clinical  examination  was  done.  Pulse  rate,  Blood 
pressure  &  temperature  noted.  Symphysiofundal  height  was  measured. 
Uterine size,  presentation & adequacy of amniotic  fluid clinically, were 
noted. Fetal heart rate was counted. Speculum & pervaginal examination 
was done to rule out draining P/V and confirm the membranes.
Necessary investigations done. A Non stress test  was done.
An  Ultrasound  examination  was  done  for  fetal  well  being  and 
amniotic fluid index was measured by the technique described by Phelan 
et al (1987 ).
 A , curvilinear transducer is used. 
By marking, the uterus  is divided into four quadrants using the 
maternal sagittal midline vertically and an arbitary transverse line 
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approximately half way between the symphysis pubis and upper 
edge of uterine fundus.
The transducer was kept parallel to the maternal sagittal plane and 
perpendicular to the maternal coronal plane throughout. 
     
The  deepest,  unobstructed  and  clear  pocket  of  amniotic  fluid 
visualized and image was frozen. The ultrasound calipers are manipulated 
in such a way to measure the pocket in a strictly vertical direction. The 
process is repeated in each of the four quadrants and pocket measurement 
are summed to give the  AFI. Patients are grouped according to their AFI, 
as AFI 5 cm or less and control group > 5cms. The patients are followed 
up by observing the mode of delivery, if delivery is made by caesarean 
section, the indication are recorded. The condition of babies is assessed by 
birth weight, apgar score, color of liquor and the need for neonatal
admission. These babies were followed till 28 days after birth.
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                                                 OBSERVATION
The present study is under taken to study the outcome of term 
pregnancy with amniotic fluid index 5 cm or less (study group) and control 
group >5 cm 
  Total numbers of patients selected were 150 cases in each group.
                                       
                               
AGE DISTRIBUTIONS OF PATIENTS
  
  AFI <5cm Control group  
AGE 
  
 No           %   No           %
< 20yrs
 
   10    7    6   4
20 - 30yrs    131   87  139  93
> 30yrs      9    6    5   3 
Total     150 100 150 100
                                        X2 = 2.38 P = 0.30
                     It can be found from the above table that
Majority of cases are in the age group of 20 to 30 Yrs 
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DISTRIBUTION OF CASES WITH PARITY
  
Parity AFI ≤ 5cm
NO          %
Control group
     NO             %
PRIMI 83 55 85 57
MULTI 67 45 65 43
TOTAL 150 100 150 100
 X2  = 0.05 P = 0.81
From the above table,
In AFI ≤ 5 -   55% were primi and 45% were multi.
In control group, 57% were primi and 43% were multi.  But 
the difference was found to be non-significant.
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MODE OF DELIVERY
   MODE
    AFI   < 5cm Control group
    No %       No    %  
    
VAGINAL 55 37 94 63
         Primary
LSCS
               RPT
74
21
95
78
22
63
34
     
22
56
61
39
37
TOTAL 150 100 150 100
X2 = 20.28 P = 0.001 OR = 2.90
In AFI ≤  5cm, 37% had vaginal delivery and 63% had LSCS.  22% were 
repeat CS.    
In control group, 63% had vaginal delivery and 37% had LSCS.  39% were 
repeat CS.
          
.
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INDICATION FOR CAESAREAN SECTION
From the above table,
         
          In AFI ≤5cm 51%of patients under went LSCS for fetal distress.
In control group 29% of patients under went LSCS for fetal distress. 
The difference was found to be significant.(P=0.05)
Indication
For caesarean
Section
AFI ≤ 5cm Control group
No    %     No       %
Total
Fetal distress
48 51 16 29 64
Z=4.29
P=0.05
CPD 8 8 15 27 23
IUGR 11 12 5 9 16
Failed Induction 10 11 8 14 18
Breech 13 13 6 10 19
Others 5 5 6 11 11
Total 95 100 56 100 151
                                     
                                   
INDUCTION OF LABOUR.
                            AFI ≤5cm
                              NO           %
Control group
NO           %
No.of Induction 48 42 38 25
Vaginal delivery 12 25 26 68
LSCS 36 75 12 32
 
        
              X2 = 16.21               P = 0.001              CI (2.3-19)
Induction of labour is 42% vs 25% in AFI < or =5cm and 
control group.
                    .
  
                    
          
3
2
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COLOUR OF LIQUOR
Liquor colour       AFI ≤5cm
       
Control group
    No       %    No       %
Total
Clear 82 54 112 75 194
Thin 30 20 27 18 57
Thick 38 26 11 7 49
X2 = 1.19 P = 0.17
26% of patients ,in AFI ≤ 5 had thick meconium and only 7% of 
patients in control group had thick meconium
The difference was found to be non significant. (P = 0.17)  
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BIRTH WEIGHT
                                
Birth weight
    AFI< 5cm Control group
    No       %    No      %      Total
>3kg 16 11 29 19 45
2.5-3kg 72 48 83 55 155
2-2.5 24 16 25 17 49
<2 28 18 8 5 36
           
X2 = 15.6 P = 0.001
About 18% of babies in AFI≤5cm are below 2kg only 5% of babies 
in control group are below 2kg. The difference was found to be significant 
(P = 0.001)
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APGAR SCORE
Apgar @ 
5 Minutes 
   AFI 5cm or Less 
      No           %
Control Group
    No                 %
< 4 5 3 1 0.6
<7 16 11 2 2
>7 134 88 148 98
X2 = 9.99  P = 0.001   OR = 8.8  (2-56)
 In study group 11%  had apgar less than  7@ 5 minutes and in control 
group 2% had apgar less than 7@5 minutes.The difference was found to be 
significant.(P=0.001)
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NEONATAL OUTCOME
            
            In AFI≤5cm about 67% of patients had reactive NST and 33% had 
non reactive NST.
In control group,about 84%of patients had reactive NST and 16% 
had non reactive NST. The difference was found to be significant. 
(P=0.002) 
  
      NST
    AFI <5cm   Control group
       
       No      %  No     %
REACTIVE
Neonatal
Death
    101
     
      2
     67
      
     2
   126
     
    -
  84
  
    -
NON-REACTIVE   
Neonatal death
     49
       7
     33 
       
    14
24
  1
   16
      -
X2=9.3
P=0.02
OR=8(2-40)
Total Neonatal death        9 
 
  6   1     0.3 Z=2.29
P=0.02
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NEONATAL OUTCOME
               AFI≤5cm     Control group
     No       %     No      %
NICU admission 69 46% 25 17% Z=5.28
P=0.001
Discharged 60 87% 24 96%
Preterm 10 7% 4 3%
IUGR 39 26% 10 7%
Neonatal death 9 6% 1 0.3%
In AFI < or = 5 cm,46% of babies had NICU admission, 87% of 
babies were discharged. 6% of neonatal death. 
In control group 17% 0f babies had NICU admission 96% of babies 
were discharged. 0.3% neonatal death. The difference was found to be 
significant.
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PERI NATAL OUTCOME IN AFI < 5cm
Reactive NST
 No               %
Non Reactive NST
    No            %
Mode of 
delivery 
Vaginal 
LSCS
45
56
45
55
10
39
20
80
X2= 8.28
P=0.004
OR=3.1 (1-7.6)
Apgar @ 5 min
1. Less than 7
2. > 7
5
96
5
95
11
38
22
78
X2=10.6
P=0.001
OR=5.6 (1.6-20)
NICU admission 37 37 32 65
Z=3.05
P=0.002
CI=28%
Neonatal Death 2 2 7 14
Z=1.82
P=0.02
CI=9%
In study group reactive NST is compared with NR NST.
1. In Reactive NST 45% has vaginal, 55% had LSCS
    Non-reactive NST 20% had vaginal 80% had LSCS
    The difference was found to be significant (P=0.004)
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2. In Reactive NST 5% had Apgar less than 7@ 5 min Vs 22% in NR NST. 
The difference was found to be significant (P=0.001).
3. In Reactive NST 37% had NICU admission, about 65% in NR NST 
group had NICU admission. The difference was found to be  significant.
(P=0.002)
4. In Reactive NST 2% had Neonatal Death. 14% of Non reactive NST had 
Neonatal. Death. The difference was found to be significant. (P=0.02).
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CONTROL GROUP
Reactive NST
No                 %
Non Reactive NST
No                  %
Mode of 
delivery
Vaginal
LSCS
86
40
68
32
8
16
33
67
X2 = 10.51
P = 0.001
Apgar @ 5 min
1.Less than 7
2.> 7
1
125
0.8
99.2
2
22
8
91
X2 = 5.85
P = 0.02
NICU 
admission
Neonatal Death
16
-
13
-
9
1
38
4 Z = 2.58
P = 0.10
The risk of apgar less than 7 @ 5 min is 8% in NRNST and 0.8 in 
reactive NST
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DISCUSSION
Oligohydramnios AFI less than or equal to 5cm is associated with 
increased  perinatal  morbidity  and  mortality.  With  Oligohydramnios 
meconium, Fetal heart rate abnormalities and low apgar scores are more 
frequent.  Neonatal  & Fetal  acidosis  rates  were  doubled  compared  with 
controls (Moore et al 1997) fetal distress requiring operative intervention 
was tripled compared with   control.
In this study 150 cases with  AFI  5cm or less is compared with 
control group  150 cases with AFI > 5cm.
In the study group – 27 cases of preeclampsia,26 cases of post EDD,
22 cases of previous LSCS,13 cases of breech. 
In control group –19 cases of preeclampsia,13 cases of post EDD,
25 cases of previous LSCS,6 cases of breech presentation were taken.
  In a study conducted by Casey & Coworkers B.M.2001 pregnancy 
outcomes after antepartum diagnosis of oligohydramnios at or beyond 34 
weeks  gestation  in  147  cases.  This  complication  was  associated  with 
increase in labour induction(42% vs 18%).Non reassuring heart rate 
(48%  vs  39%).NICU  admission  (7  %  vs  2%),  MSAF  (1  %  vs 
0.1% ),neonatal death rate (5 % vs 0.3%).
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In  a  study  by  Golan  &  cowokers  (1994) fetal  outcome  in  145 
cases,they  found  increase  incidence  of  fetal  distress,  MSAF(29.1%) 
IUGR(24.5%)  Breech  17%.Asphyxia  during  labour  11.5%  ,  corrected 
PNMR –10%.
In a  study by  Chamberlain  & coworkers  1993,the  incidence  of 
major congenital anomaly &IUGR significant related to qualitative AF.
In a study by Youseef et al 1993 in South Med Journal 
Measurement of AFI and Fetal outcome was studied in term pregnancies 
with AFI less than 5 cm and found AFI is superior in detucting fetal 
outcome.
In study by Locatelli A 2004 as perinatal outcome associated with 
oligohydramnios in uncomplicated term pregnancies 40-41.6 weeks 
.oligohydramnios independently associated with a higher risk of low birth 
weight percentile.
In study by  Baron C & Coworkers 2000 on impact  of AFV on 
Intrapartum on perinatal outcome.AFI less than or equal to 5 cm compared 
with  Normal.The  efficacy  of  oligohydramnios  predicting  caesarean 
delivery for fetal distress gave a sensitivity of 78% a specificity of 74%, 
+ve predictive value 33% and -ve predictive value 95%.The AFI for 
              4
3
detecting  intrapartum  oligohydramnios  is  a  valuable  screening  test  for 
subsequent fetal distress requiring caesarean delivery.
In a study by  Chauhan.SP & coworkers 1999 an antepartum & 
intrapartum amniotic fluid index of ≤5 cm is associated with a significantly 
increased risk of  CS delivery for  fetal  distress  and low apgar scores at 
5mins.
PRESENT STUDY
   In this study perinatal outcome in 150 cases AFI ≤ 5 cm and 150 
cases of control group are studied. In  AFI  ≤5 cm, 55 patients had vaginal 
delivery & 95 patients had LSCS (74PrimaryCS + 21 Rpt LSCS).
In control group about 94 patients had vaginal delivery,56 patients  had 
LSCS(34PrimaryCS + 22 Rpt LSCS)
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INDUCTION OF LABOUR:
INDUCTION AFI <5 cm Control Group
Present Study 42% 25%
Casey Co Workers
         (2000)
42% 18%
Induction of labour is comparable with  the study by Casey  & 
coworkers in AmJOG 2000
In present study 48 cases in AFI  ≤ 5 cm & 30 cases in control group 
were induced.
AFI ≤   5 cm------ Labour Natural -12
Emg LSCS -36
Control group------Labour Natural -18
Emg LSCS -12
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CAESAREAN  SECTION FOR FETAL DISTRESS:
Youseef et al (1993) 86.6%
Baron Morgan et al
           (2000)
78%
Present Study 75%
The efficacy of oligohydramnios  predicting  CS for Fetal distress 
has sensitivity of 78% comparable with   various studies .
MECONIUM STAINED LIQUOR
Youseef et al (1993) 63.6%
Present Study 64%
The sensitivity of meconium stained liquor is 64% comparable 
with  study. 
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APGAR SCORE less than 7 @5min.
Youseef et al(1993) 88.8%
Present Study 85%
The sensitivity of oligohydraminos in predicting apgar less than 7 @ 
5 min is comparable.
IUGR
Youseef et al (1993) 79.9%
Present Study 79%
 The sensitivity of AFI measurement of   ≤ 5 cm is comparable with 
study.
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PERINATAL MORTALITY
(American Journal of Obs & Gyn. 2000)
Neonatal AFI < 5 cm Control Group
Present Study 6% 0.3%
Casey Co Workers 
(2000)
5% 0.3%
Neonatal death rate is comparable with study.
NEONATAL DEATH
• In study group there were 9 neonatal deaths out of this 8 were 
due to complications of IUGR, In control group 1 neonatal death.
• Case No – 15.Maheswari  23F Primi. Unbooked, GA – 41 weeks 
3 days on admission with NR –NST,AFI 3.4 cm ,with 
unfavourable cervix. Emergency LSCS done indication IUGR 
with fetal distress. Alive boy, 1.75 kg apgar   7/10, 8/10,thick 
meconium, admitted in NICU. Term IUGR Baby had NNEC, 
meningitis , Jaundice , died after one week .
   48
• Case No – 19.Amsavalli 19F Primi Unbooked, GA – 38 weeks 4 
days, breech presentation,AFI- 3 cm, NST-NR.Emergency LSCS 
done  immediately in view of severe oligohydramnios and breech 
presentation. indication IUGR.  breech with fetal distress. Alive 
boy,1.65 kg apgar  6/10,7/10,thin meconium admitted in NICU. 
Baby died after two days due to RDS.
• Case No-22.zeenath 24F Primi. Booked, GA – 38 weeks on 
admission NR NST,AFI – 4, with thick meconium  in early 
labour taken for Emergency  LSCS 
within  30 min.Alive boy 1.7 kg 6/10.7/10. thick Meconium. 
IUGR admitted in  NICU died after one day due to MAS 
• Case No – 58 .Rajakumari 24F Primi. Unbooked, GA – 39 weeks 
3 days NST – variable deceleration AFI  - 4 cm, with 
Unfavourable cervix. Emergency LSCS indication fetal distress. 
Alive girl – 2.9 kg 6/10.7/10. clear liquor. Admitted in NICU 
died after 2 days due to RDS.
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• Case No – 86.Shanthi 23F Primi.Unbooked,GA  - 37 weeks 4 
days NST – Reactive, AFI – 3 cm .spontaneous labour, labour 
natural Alive girls 1.5 kg 7/10.8/10. clear liquor. Term IUGR 
Admitted in NICU. Baby had recurrent seizures, 
meningitis,NNEC died after 5 days.
• Case No – 91.Regina. 24F Primi. Booked, Preeclampsia.GA – 38 
weeks 5 days NST – reactive, Unfavourable cervix . Induced 
with PGE 2  gel twice  not responded.Emergency LSCS 
indication IUGR with failed induction. Alive boy 1.6kg, 
6/10.8/10. thin meconium. Term IUGR admitted in NICU. Baby 
had Polycythemia and died after 2 days due to Pulmonary 
haemorrhage.
• Case No – 98.Narasamma.32F G2 A1 Md 8 Yrs Unbooked GA – 
39 weeks NST – NR ,AFI - <2 . Doppler High resistance flow, 
transverse  lie.In View of severe Oligo hydramnios transverse lie, 
long period of infertility Emergency LSCS done Alive Girl – 
1.4kg , 3/10.6/10 . thick meconium admitted in NICU. Baby died 
after 3 days due to perinatal asphyxia.
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• Case No – 113.Hemalatha.22F G2 P1 L1 Prev LSCS, Booked 
GA – 39 weeks AFI – 2 .Admitted with decreased fetal 
movement NST – NR, with Unfavourable cervix .Emergency 
repeat LSCS done  Alive boy – 2.6 kg.2/10.3/10.thick meconium 
term IUGR admitted in NICU. Baby died after 2 hours due to 
MAS.
• Case No – 118.Kiruparani.23F G3 A2 . Md 4 Yrs Booked GA – 
39weeks AFI- 2 NST – NR with Unfavourable cervix Emergency 
LSCS done indication severe Oligohydramnios with IUGR.Alive 
Boy – 1.8kg 7/10.8/10.  thick meconium, Term IUGR ,PN 
hypoxia,HIE III  Admitted in NICU . Baby died after 2 days
• In control group
 Case No – 83.Dhanalakshmi 25F G1 severe Preeclampsia, 
Unbooked GA 39 weeks, AFI 8.9cm, NST – NR,Doppler MCA 
Increase diastolic flow with Unfavourable cervix. Induced with 
PGE2 gel Not – responded Emerancy LSCS done indication severe 
PET IUGR with fetal distress.Alive girl 1.6kg,3/10.4/10.thin 
meconium Term IUGR HIE III Admitted in NICU. Baby discharged 
after 7 days, died 8 days after discharge at home.
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SUMMARY
 In this study perinatal outcome in AFI 5cm or less compared with
        control group.
 About 150 cases were studied in each group.
• 87% in study group & 93% in control group were in the age group 
        20 - 30yrs.
• In study group 37% had vaginal & 63% has LSCS(22% were repeat 
LSCS). In control group 63% had vaginal & 37% had LSCS delivery 
(39% were Repeat LSCS)
• The risk of CS for fetal distress found to be higher in study group than
         control (32 Vs 11%,) The difference was found to be significant  
         (P=0.05).
• In study group, induction was found to be higher than control 
        (42% Vs 25%). The difference was found to be significant. (P=0.003)
• Meconium stained liquor was 46% in study group, 25% in control
       group. The difference was not significant (P=0.17).
• In study group 11% had apgar score <7 @ 5 min Vs 1% in control
        group.The difference was found to be significant. (P=0.001)
• In study group 18% of babies were less than 2 kg, 5% in control group
        were less than 2 kg. The difference was found to be  significant.  
        (P=0.001).
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• In study group about 67% had reactive NST & 33% had NR NST. In
       Control group 84% had Reactive NST, 16% had Non reactive NST.  
        (P=0.002)
• In Oligohydramnios (Study Group) 
               The risk of apgar less than 7 at 5 minutes is high in Non
        reactive NST (22%) Vs 5% in Reactive NST.
              The risk of NICU admission was found to be high in Non-reactive 
     NST (65%) Vs 37% in Reactive NST. The difference was found to be 
     significant. (P= 0.002).
     Neonatal death is 12% in Non-reactive NST and 3% in Reactive  
     NST. The difference was found to be significant. (P = 0.02).
In control group - the risk of  apgar less than 7@ 5 min is only 8% in Non 
reactive NST and 0.8 in reactive NST.
The risk of NICU admission is 38% in Non-Reactive NST, 13% in 
Reactive NST.The difference was found to be significant.(P=0.02).
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CONCLUSION
• Oligohydramnios is associated with adverse perinatal outcome.
• Oligohydramnios with reactive NST is associated with good 
prognosis (good apgar, decreased NICU admission & neonatal 
death).
• Oligohydramnios with non reactive NST needs careful monitoring 
and eventuates in early delivery. It increases the incidence of 
caesarean delivery for fetal distress, NICU admission, low apgar at 5 
mins and Neonatal death.
• Oligohydramnios associated with IUGR carries a poor perinatal 
outcome (increased neonatal death, NICU admission, increased rate 
of CS for fetal distress, very low birth weight) Hence they need 
good neonatal care.
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PROFORMA
Name Age Unit IP No. G  P  L  A
Address Md Since
Booked / Unbooked DOA
Menstural History LMP –
EDD –
Maternal Complication
G.E – Anemia / Pedal Edema / Temp
Obstetric Examination
Ht of fundus – 
Presentation – 
FHR -
Liquor clinically - Adequate / Not Adequate 
Investigations:
Urine - Albumin Hb % - Other investigations
   Sugar Blood group
   Deposits
USG – GA –
 Placenta NST – Reactive / Non reactive
FH
AFI 
Mode of Delivery
Spontaneous Induction
Vaginal Instrumental LSCS - EMG/Elective
Induction Delivery Interval
Drip given / not
FHR Variation
Duration of Labour – 
Rupture of Memb – 
Colour of Liquor – 
Baby Details:
Cried after birth - Yes / No
Sex - Boy / Girl
Wt -
Apgar -
Baby Resucitated -
Admission in NICU - Yes / No Days – 
MSAF - Yes / No
Associated Complication
for baby -
Follow up:
Whether Baby discharged in good condition.
28 Days follow up – 
         
                 EXPANSION OF ABBREVIATIONS
AF - Amniotic Fluid
AFI - Amniotic Fluid Index
AFV - Amniotic Fluid Volume
H - Foetal Heart
GA - Gestational Age
LSCS - Lower Segment Caesarean Section
NST - Non Stress Test
    
